A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin
Clinical trial NCT01482377 · COMPLETED
Trial details
- NCT number
- NCT01482377
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2016-02-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.